The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy of VIP152, a CDK9 inhibitor, in patients with double-hit lymphoma (DHL).
 
Victor Moreno
Employment - START
Consulting or Advisory Role - Basilea; Bayer; BMS; Janssen Oncology; Merck; Roche
Speakers' Bureau - Bayer
Research Funding - Abbvie (Inst); ACEA Biosciences (Inst); Adaptimmune (Inst); Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); BeiGene (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); E-therapeutics (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Menarini (Inst); Merck (Inst); Nanobiotix (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); PsiOxus Therapeutics (Inst); Puma Biotechnology (Inst); Regeneron (Inst); RigonTEC (Inst); Roche (Inst); Sanofi (Inst); Sierra Oncology (Inst); Synthon (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Tesaro (Inst); Transgene (Inst)
Expert Testimony - Medscape/Bayer; Nanobiotix
Travel, Accommodations, Expenses - Sanofi/Regeneron
Other Relationship - BMS
 
Raul Cordoba
Consulting or Advisory Role - Celgene/Bristol-Myers Squibb; Incyte; Janssen; Kite/Gilead; Kyowa-Kirin; Takeda
Speakers' Bureau - Abbvie; AstraZeneca; Roche
Research Funding - Pfizer
Travel, Accommodations, Expenses - Abbvie; Janssen; Roche
 
Daniel Morillo
Honoraria - Janssen; Takeda
Travel, Accommodations, Expenses - Celgene; Janssen; Kite, a Gilead Company; Takeda
 
Jennifer Robinson Diamond
Consulting or Advisory Role - immunomedics
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Deciphera (Inst); Immunomedics (Inst); MedImmune (Inst); Merck (Inst); Millennium (Inst); OnKure (Inst); Rexahn Pharmaceuticals (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Medimmune
 
Ahmed M. Hamdy
Employment - Vincerx Pharma
Leadership - Vincerx Pharma
Stock and Other Ownership Interests - Acerta Pharma; AstraZeneca/MedImmune; Vincerx Pharma
 
Raquel Izumi
Employment - Vincerx Pharma
Leadership - Vincerx Pharma
Stock and Other Ownership Interests - Acerta Pharma; AstraZeneca; Vincerx Pharma
Expert Testimony - Diablo Valley Oncology; Hematology Medical Group
 
Claudia Merz
Employment - Bayer
 
Oliver Boix
Employment - Bayer
Stock and Other Ownership Interests - Bayer
 
Isabelle Genvresse
Employment - Bayer
 
Grzegorz S. Nowakowski
Consulting or Advisory Role - Celgene (Inst); Debiopharm Group; Genentech (Inst); Kite/Gilead; MorphoSys (Inst); Selvita
Research Funding - Celgene (Inst); MorphoSys (Inst); NanoString Technologies (Inst)